Dr. Changping Gu | Anesthesiology | Best Researcher Award

Shandong First Medical University Affiliated Provincial Hospital, China

Dr. Gu Changping, MD, Ph.D., is a leading anesthesiologist and perioperative medicine researcher, currently serving as Director at the Provincial Hospital affiliated with Shandong First Medical University and Professor in the Clinical Department. He earned his Ph.D. in Anesthesiology from Shandong University in 2015 and completed postdoctoral research at the University of Illinois, Chicago, and Harvard Medical School, gaining extensive international exposure. Over his career, Dr. Gu has held progressive clinical and academic roles, including Chief Physician, Associate Chief Physician, and Attending Physician at Shandong University-affiliated hospitals. His research interests focus on perioperative organ protection, mechanical ventilation-induced lung injury, inflammation, energy metabolism, and vascular permeability. He has led and contributed to multiple national and provincial-level projects investigating mitochondrial homeostasis, pulmonary protection strategies, and molecular mechanisms underlying ventilator-induced lung injury. Dr. Gu has authored 40 publications with 519 citations and an h-index of 11, published in top-tier journals including CNS Neurosci Ther, ACS Applied Materials & Interfaces, Int Immunopharmacol, BMJ Open, and Frontiers in Cardiovascular Medicine. He holds four invention patents, authored four books, and contributed to expert consensus documents in anesthesia management. He has served in key leadership positions such as Deputy Director of the Perioperative Medicine Branch, member of standing committees, and editorial board member of international journals. His awards and honors include the Taishan Scholar Young Expert of Shandong Province, multiple provincial and national-level research prizes from the Chinese Medical Association and Shandong Provincial Government, and recognition for excellence in clinical and academic contributions. Dr. Gu has actively represented Chinese anesthesiology at international conferences and expos, delivering keynote presentations and facilitating cross-border collaborations. With his extensive expertise, robust publication record, leadership experience, and ongoing research initiatives, Dr. Gu Changping demonstrates exceptional potential to advance perioperative medicine, enhance patient care, mentor future researchers, and contribute significantly to global medical science, making him a deserving candidate for international recognition.

Profile: Scopus

Featured Publications

1. Zhang, Y., Cao, C., Sun, C., Yan, J., Wang, Y., & Gu, C. (2025). The SIRT1/GPS2/AIP1 axis regulates pulmonary vascular permeability in ventilator-induced lung injury. Molecular and Cellular Biochemistry. Advance online publication.

2. Wang, X., Yan, J., Zhao, Y., Li, S., Ma, Z., Duan, X., Wang, Y., Jiao, J., Gu, C., & Zhang, G. (2025). Targeted degradation of EGFR mutations via self-delivery nano-PROTACs for boosting tumor synergistic immunotherapy. ACS Applied Materials & Interfaces, 17(14), 20943–20956.

3. Wang, B., Gu, A., Yan, J., Zhang, Y., Liu, J., Sun, C., Wei, Y., Gu, C., & Wang, Y. (2025). Kaempferol alleviates sepsis-related acute lung injury by inhibiting the activation of alveolar macrophages mediated by extracellular vesicles from alveolar epithelial cells. International Immunopharmacology, 162, 115130.

4. Yan, J., Wang, X., Zhao, Y., Li, S., Ma, Z., Yang, Y., Gu, C., Zhang, G., & Wang, Y. (2025). Inflammation-responsive nanoparticles for acute lung injury treatment through gas therapy and removal of neutrophil extracellular traps. Chemical Engineering Journal, 515, 163660.

5. Zhang, Y., Sun, C., Wang, B., Gu, A., Zhou, Z., & Gu, C. (2024). Brain-derived exosomal miR-9-5p induces ferroptosis in traumatic brain injury-induced acute lung injury by targeting Scd1. CNS Neuroscience & Therapeutics, 30(12), e70189.